Roundtable: Global (2) - Minimising Dispute Risk for AI and Machine Learning Collaborations

19 Jan 2027
Pharma & Biotech Roundtables
AI and machine learning R&D collaborations represent largely uncharted territory for life science IP and transactions counsel. This roundtable addresses best practices for drafting AI-focused R&D collaborations and explores safeguards companies can put in place to minimise the risk of future disputes in this space.